---
figid: PMC8411019__bt-29-5-455-f2
figtitle: Specialized Proresolving Mediators for Therapeutic Interventions Targeting
  Metabolic and Inflammatory Disorders
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC8411019
filename: bt-29-5-455-f2.jpg
figlink: /pmc/articles/PMC8411019/figure/F2/
number: F2
caption: SPM receptors and associated intracellular signaling pathways. SPMs signal
  through specific G-protein coupled receptors (GPCRs). RvD1, RvD3 and LXA4 are agonist
  for ALX/FPR2 and its activity leads to PKA activation to phosphorylate CREB promoting
  production of anti-inflammatory cytokines, macrophage polarization. RvD1 also influences
  AKT phosphorylation via PI3K pathway to inhibit NF-kB mediated pro-inflammatory
  effects. It also enhances ERK1/2 phosphorylation via MEK1/2 to induce anti-inflammatory
  effects. RvD2 works through DRV2, leading to ERK1/2 or PLC pathway to promote resolution.
  RvE1 is an agonist for ChemR23 and BLT1. The ChemR23-RvE1 downstream signaling activates
  AKT phosphorylation, inhibiting NF-kB inflammatory effects. PD1-GPR37 mechanistic
  actions also found to block PKA activation. MaR1 acts via two distinct receptors,
  LGR6 and RORα. MaR1 activates RORα transcriptional activity, leading to M2 polarization
  and 12-LOX expression, an enzyme required for MaR1 syntheis. MaR1 activates LGR6-mediated
  cAMP signaling to promote macrophage efferocytosis and resolution.
papertitle: Specialized Proresolving Mediators for Therapeutic Interventions Targeting
  Metabolic and Inflammatory Disorders.
reftext: Yong-Hyun Han, et al. Biomol Ther (Seoul). 2021 Sep 1;29(5):455-464.
year: '2021'
doi: 10.4062/biomolther.2021.094
journal_title: Biomolecules & Therapeutics
journal_nlm_ta: Biomol Ther (Seoul)
publisher_name: The Korean Society of Applied Pharmacology
keywords: Specialized pro-resolving mediators | Resolvins | Maresins | NAFLDs | Adipose
  tissue
automl_pathway: 0.9129676
figid_alias: PMC8411019__F2
figtype: Figure
redirect_from: /figures/PMC8411019__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8411019__bt-29-5-455-f2.html
  '@type': Dataset
  description: SPM receptors and associated intracellular signaling pathways. SPMs
    signal through specific G-protein coupled receptors (GPCRs). RvD1, RvD3 and LXA4
    are agonist for ALX/FPR2 and its activity leads to PKA activation to phosphorylate
    CREB promoting production of anti-inflammatory cytokines, macrophage polarization.
    RvD1 also influences AKT phosphorylation via PI3K pathway to inhibit NF-kB mediated
    pro-inflammatory effects. It also enhances ERK1/2 phosphorylation via MEK1/2 to
    induce anti-inflammatory effects. RvD2 works through DRV2, leading to ERK1/2 or
    PLC pathway to promote resolution. RvE1 is an agonist for ChemR23 and BLT1. The
    ChemR23-RvE1 downstream signaling activates AKT phosphorylation, inhibiting NF-kB
    inflammatory effects. PD1-GPR37 mechanistic actions also found to block PKA activation.
    MaR1 acts via two distinct receptors, LGR6 and RORα. MaR1 activates RORα transcriptional
    activity, leading to M2 polarization and 12-LOX expression, an enzyme required
    for MaR1 syntheis. MaR1 activates LGR6-mediated cAMP signaling to promote macrophage
    efferocytosis and resolution.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Lgr6
  - Rora
  - Fpr2
  - Fpr3
  - Hsh2d
  - gs
  - Gs
  - ac
  - Alox12e
  - Hspg2
  - Pik3r1
  - Akt1
  - Creb1
  - Cmklr1
  - Nfkb1
  - Mdk
  - Ephb2
  - Mapk1
  - Ugt2b5
  - Gpr18
  - Pdcd1
  - Gpr37
  - Alox15
  - Gpr32
  - Prkcg
  - Pik3cg
  - Ephb1
  - LGR6
  - RORA
  - FPR2
  - HSH2D
  - GNAS
  - GNAL
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - ALOX12
  - ALOX15
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - GPR32
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - CMKLR1
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - NFKB1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - GPR18
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - PDCD1
  - RPL17
  - SNCA
  - SPATA2
  - RPL17-C18orf32
  - GPR37
  - Ror
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - gl
  - sno
  - norpA
  - sl
  - Plc21C
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - CrebB
  - CrebA
  - Go
  - Dif
  - dl
  - Rel
  - Dsor1
  - Mtk
  - Erk7
  - rl
---
